Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?
about
Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriersMupirocin ointment for preventing Staphylococcus aureus infections in nasal carriersPhenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South AfricaProspects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.Toward an understanding of the evolution of Staphylococcus aureus strain USA300 during colonization in community householdsAminoacyl-tRNA synthetases: essential and still promising targets for new anti-infective agents.Recent advances in the chemistry and biology of naturally occurring antibiotics.Novel targets for antibiotics in Staphylococcus aureus.Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques.A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions.Mupirocin ointment prevents early post-tympanostomy tube otorrhea: a preliminary study.Antibacterial activity of REP8839, a new antibiotic for topical use.Folliculitis decalvans: successful treatment with a combination of rifampicin and topical mupirocin.Mupirocin resistance in clinical isolates of Staphylococcus aureus.Should we routinely use mupirocin to prevent staphylococcal infections?Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality.
P2860
Q24241136-A56259FA-87CE-41C1-A5E1-90D473F9E35FQ24244819-9014CAD6-3603-40D3-A340-1C9CEB5ECED4Q33403622-DFE0CB94-9224-47EA-94E3-7E608E995A11Q36320180-FB200A4D-606E-4310-9D0B-5ADD0DC51626Q36525045-A3F019A2-EBE2-4871-ADEB-D588C960E4DFQ36802598-DD84BBE1-38B5-499A-A9E0-ACCD9C90C448Q37313939-81FB712D-F6BA-4661-9DD4-DDB0EC1D2654Q40149893-BA41EEA2-B886-4E8D-B970-5C5297FE7D8EQ40289356-AFF411EB-EDBD-4D16-A9FB-985AA1004A5CQ40937956-8BF9BA42-A3EF-4388-8FE8-0593169ABF22Q41885792-774E27A2-5189-472C-A0D3-99781F38D1BCQ42112582-E0B9C548-6CE1-4625-ADD2-3B1938A306FAQ43979666-99C2EA4A-3C9F-49F3-A172-8149A2E86DE5Q44425796-20C803A6-B46D-483D-9648-67D2B539F179Q44771600-E03095B6-8EB4-4911-A123-515A7E45C1C2Q54210717-410953F5-7FB0-4585-9C09-F9B2A0A27A14
P2860
Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?
@ast
Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?
@en
type
label
Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?
@ast
Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?
@en
prefLabel
Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?
@ast
Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?
@en
P2860
P1476
Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?
@en
P2093
P2860
P304
P356
10.1179/JOC.1999.11.5.331
P577
1999-10-01T00:00:00Z